These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 29596661)

  • 1. Mitochondrial Agents for Bipolar Disorder.
    Pereira C; Chavarria V; Vian J; Ashton MM; Berk M; Marx W; Dean OM
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):550-569. PubMed ID: 29596661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
    Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
    Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy.
    Callaly E; Walder K; Morris G; Maes M; Debnath M; Berk M
    Mini Rev Med Chem; 2015; 15(5):355-65. PubMed ID: 25807948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine in the maintenance treatment of bipolar disorder.
    Vasudev A; Macritchie K; Watson S; Geddes JR; Young AH
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD005171. PubMed ID: 18254071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.
    Strech D; Soltmann B; Weikert B; Bauer M; Pfennig A
    J Clin Psychiatry; 2011 Sep; 72(9):1214-21. PubMed ID: 21294992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological agents under research for the maintenance treatment in bipolar disorder.
    Dimitrakopoulos S; Konstantakopoulos G
    Psychiatriki; 2015; 26(3):169-80. PubMed ID: 26480221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiagabine in the maintenance treatment of bipolar disorders.
    Young AH; Geddes JR; Macritchie K; Rao SN; Vasudev A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005173. PubMed ID: 16856081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC; Gershon S
    Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
    Liu HY; Potter MP; Woodworth KY; Yorks DM; Petty CR; Wozniak JR; Faraone SV; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):749-62.e39. PubMed ID: 21784295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen use for the management of mania: a review of current preclinical evidence.
    Armani F; Andersen ML; Galduróz JC
    Psychopharmacology (Berl); 2014 Feb; 231(4):639-49. PubMed ID: 24441937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiagabine in the maintenance treatment of bipolar disorder.
    Vasudev A; Macritchie K; Rao SN; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005173. PubMed ID: 22161389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability.
    Young AH; Geddes JR; Macritchie K; Rao SN; Watson S; Vasudev A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004694. PubMed ID: 16856056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate for acute mood episodes in bipolar disorder.
    Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
    Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin treatment for bipolar disorders.
    Maidment ID
    Ann Pharmacother; 2001 Oct; 35(10):1264-9. PubMed ID: 11675857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.
    Zarate CA; Manji HK
    CNS Drugs; 2009; 23(7):569-82. PubMed ID: 19552485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development.
    Nierenberg AA; Kansky C; Brennan BP; Shelton RC; Perlis R; Iosifescu DV
    Aust N Z J Psychiatry; 2013 Jan; 47(1):26-42. PubMed ID: 22711881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.